124 related articles for article (PubMed ID: 34306405)
1. Expression and clinical significance of miR-338 and miR-20a in serum of patients with gastric carcinoma.
Li M; Feng J; Gao C; Sun W; Chen Y
Am J Transl Res; 2021; 13(6):6620-6628. PubMed ID: 34306405
[TBL] [Abstract][Full Text] [Related]
2. Clinical value of miR-135 and miR-20a combined with multi-detector computed tomography in the diagnosis of gastric cancer.
Han W; Bu X; Liu Y; Liu F; Ren Y; Cui Y; Kong S
World J Surg Oncol; 2021 Sep; 19(1):283. PubMed ID: 34537058
[TBL] [Abstract][Full Text] [Related]
3. Serum miR-20a is a promising biomarker for gastric cancer.
Yang R; Fu Y; Zeng Y; Xiang M; Yin Y; Li L; Xu H; Zhong J; Zeng X
Biomed Rep; 2017 Apr; 6(4):429-434. PubMed ID: 28413641
[TBL] [Abstract][Full Text] [Related]
4. Expression of serum miR-20a-5p, let-7a, and miR-320a and their correlations with pepsinogen in atrophic gastritis and gastric cancer: a case-control study.
Xu Q; Dong QG; Sun LP; He CY; Yuan Y
BMC Clin Pathol; 2013 Mar; 13():11. PubMed ID: 23521833
[TBL] [Abstract][Full Text] [Related]
5. MiR-1236-3p serves as a new diagnostic and prognostic biomarker for gastric cancer.
An JX; Ma ZS; Ma MH; Shao S; Cao FL; Dai DQ
Cancer Biomark; 2019; 25(2):127-132. PubMed ID: 31045511
[TBL] [Abstract][Full Text] [Related]
6. The correlation of circulating pro-angiogenic miRNAs' expressions with disease risk, clinicopathological features, and survival profiles in gastric cancer.
Peng W; Liu YN; Zhu SQ; Li WQ; Guo FC
Cancer Med; 2018 Aug; 7(8):3773-3791. PubMed ID: 30003708
[TBL] [Abstract][Full Text] [Related]
7. Circulating miRNA-20a and miRNA-203 for screening lymph node metastasis in early stage cervical cancer.
Zhao S; Yao D; Chen J; Ding N
Genet Test Mol Biomarkers; 2013 Aug; 17(8):631-6. PubMed ID: 23819812
[TBL] [Abstract][Full Text] [Related]
8. A panel of six-circulating miRNA signature in serum and its potential diagnostic value in colorectal cancer.
Maminezhad H; Ghanadian S; Pakravan K; Razmara E; Rouhollah F; Mossahebi-Mohammadi M; Babashah S
Life Sci; 2020 Oct; 258():118226. PubMed ID: 32771555
[TBL] [Abstract][Full Text] [Related]
9. Serum miR-191 and miR-425 as Diagnostic and Prognostic Markers of Advanced Gastric Cancer Can Predict the Sensitivity of FOLFOX Chemotherapy Regimen.
Bie LY; Li N; Deng WY; Lu XY; Guo P; Luo SX
Onco Targets Ther; 2020; 13():1705-1715. PubMed ID: 32158234
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of serum miR-25 as a diagnostic and prognostic biomarker in human gastric cancer.
Kong Y; Ning L; Qiu F; Yu Q; Cao B
Cancer Biomark; 2019; 24(4):477-483. PubMed ID: 30909187
[TBL] [Abstract][Full Text] [Related]
11. Expression of miR-4739 in Gastric cancer and its Relationship with Clinical Pathological Features of Patients.
Wei J; Li J; Geng D; Peng Y; Yang B; Wu H; Zhou Y
Front Surg; 2022; 9():897583. PubMed ID: 35592126
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of microRNA-20a promotes tumor progression and predicts poor prognosis of cutaneous squamous cell carcinoma.
Zhang L; Xiang P; Han X; Wu L; Li X; Xiong Z
Int J Clin Exp Pathol; 2015; 8(9):11446-51. PubMed ID: 26617873
[TBL] [Abstract][Full Text] [Related]
13. Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.
He FC; Meng WW; Qu YH; Zhou MX; He J; Lv P; Ming L
World J Gastroenterol; 2015 Apr; 21(15):4660-5. PubMed ID: 25914476
[TBL] [Abstract][Full Text] [Related]
14. Expression of plasma exosomal circLPAR1 in patients with gastric cancer and its clinical application value.
Yang X; Xia J; Peng C; Cai W
Am J Cancer Res; 2023; 13(9):4269-4276. PubMed ID: 37818058
[TBL] [Abstract][Full Text] [Related]
15. Plasma
Li B; Zhang H
Int J Clin Exp Pathol; 2017; 10(7):7356-7361. PubMed ID: 31966576
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of miR-181d is associated with poor prognosis and tumor progression of gastric cancer.
Li Z; Guo Q; Lu Y; Tian T
Cancer Biomark; 2019; 26(3):353-360. PubMed ID: 31524144
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of serum miR-647 is associated with poor prognosis in gastric cancer.
Ma H; Wang P; Li Y; Yang Y; Zhan S; Gao Y
Int J Clin Exp Pathol; 2019; 12(7):2552-2558. PubMed ID: 31934082
[TBL] [Abstract][Full Text] [Related]
18. miR-4636 inhibits tumor cell proliferation, migration and invasion, and serves as a candidate clinical biomarker for gastric cancer.
Tang J; Hu Y; Zhang C; Gong C
Oncol Lett; 2021 Jan; 21(1):33. PubMed ID: 33262825
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of miR-601 is associated with poor prognosis and tumor progression of gastric cancer.
Min C; Zhang A; Qin J
Diagn Pathol; 2019 Sep; 14(1):107. PubMed ID: 31547835
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological and prognostic significance of miR-4317 expression in gastric cancer patients.
Zhang J; Tian ZL; Zhang WT; Cheng LM; Liu J; Cao YX; Zhang ZR
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2803-2808. PubMed ID: 31002131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
